drugset / Trial / NCT02560467

Perfusion Imaging With Myocardial Contrast Echocardiography in HCM

NCT02560467

NaSingle-groupOpen-labelDiagnostic

Summary

The objective of this study is to determine whether myocardial contrast echocardiography in patients with cardiomyopathy (HCM) can detect resting hypo-perfusion due to fibrosis or stress induced perfusion defects due to associated abnormalities in intramyocardial arteries and the microcirculation. A secondary aim will be to determine whether abnormalities in perfusion are associated with either severity of symptoms (chest pain and dyspnea), presence of arrhythmias, and regional function of the septum.

Timeline

Start
2015-12-01
Primary completion
2019-09-01
Completion
2019-09-15

Drugs

EvaluationDrugModalityDoseRoute
Background Definity Diagnostic / imaging agent Intravenous
Background Lumason Diagnostic / imaging agent Intravenous
Background Regadenoson Diagnostic / imaging agent